3-deazaaristeromycin has been researched along with Acute Myelogenous Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiang, PK; Glazer, RI; Hartman, KD; Knode, MC; Marquez, VE; Richard, MM; Tseng, CK | 1 |
Aarbakke, J; Bessesen, A; Chiang, PK; Gordon, RK; Miura, GA; Prytz, PS; Slørdal, L | 1 |
2 other study(ies) available for 3-deazaaristeromycin and Acute Myelogenous Leukemia
Article | Year |
---|---|
3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60.
Topics: Adenosine; Adenosylhomocysteinase; Animals; Cell Division; Cell Line; Cell Survival; Cricetinae; Humans; Hydrolases; Leukemia, Myeloid, Acute; Liver | 1986 |
Induction of HL-60 cell differentiation by 3-deaza-(+/-)-aristeromycin, an inhibitor of S-adenosylhomocysteine hydrolase.
Topics: Adenosine; Adenosylhomocysteinase; Cell Cycle; Cell Differentiation; Cell Line; Cell Survival; Humans; Hydrolases; Leukemia, Myeloid, Acute; S-Adenosylhomocysteine; S-Adenosylmethionine | 1986 |